While iron supplementation inhibited vascular endothelial growth factor (VEGF) signaling in endothelial cells in vitro and reduced lung carcinoma vascularization in vivo [259], LCN2 supplementation resulted in ROS accumulation and increased brain endothelial cell migration which was reversible upon iron chelation [260]. This evidence concerns the gene VEGFA and lung carcinoma.